Contact
DMCA
Privacy
Robuta
https://www.biospace.com/press-releases/optinose-announces-preliminary-unaudited-fourth-quarter-2024-xhance-net-revenue-of-22-4-million
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million -...
fourth quarter
net revenue
announces
preliminary
xhance
https://www.xhance.com/
Chronic Sinusitis Treatment - XHANCE
XHANCE is a prescription medicine used to treat chronic rhinosinusitis with or without nasal polyps in adults.
chronic sinusitis
treatment
xhance